BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 1 day ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 1 day ago UP Fintech Holding Limited Reports Strong 2025 Results 1 day ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 1 day ago Cato Corporation 2025 Financial Results Summary 1 day ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 1 day ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 1 day ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 1 day ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 1 day ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 1 day ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 1 day ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 1 day ago UP Fintech Holding Limited Reports Strong 2025 Results 1 day ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 1 day ago Cato Corporation 2025 Financial Results Summary 1 day ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 1 day ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 1 day ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 1 day ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 1 day ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 1 day ago
ADVERTISEMENT
Market News

Cigna (NYSE: CI): Q3 2019 Earnings Snapshot

— Cigna Corporation (NYSE: CI) reported its third-quarter 2019 adjusted operating earnings of $4.54 per share versus $4.36 per share expected. — The results reflected strong earnings contributions led by the Health Services and Integrated Medical segments. — Total adjusted revenues soared by 213% to $35.8 billion versus $34.2 billion expected. This was driven by […]

October 31, 2019 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

— Cigna Corporation (NYSE: CI) reported its third-quarter 2019 adjusted operating earnings of $4.54 per share versus $4.36 per share expected. — The results reflected strong earnings contributions led by the Health Services and Integrated Medical segments. — Total adjusted revenues soared by 213% to $35.8 billion versus $34.2 billion expected. This was driven by […]

— Cigna Corporation (NYSE: CI) reported its third-quarter 2019 adjusted operating earnings of $4.54 per share versus $4.36 per share expected.

— The results reflected strong earnings contributions led by the Health Services and Integrated Medical segments.

Cigna (NYSE: CI): Q3 2019 Earnings Snapshot

— Total adjusted revenues soared by 213% to $35.8 billion versus $34.2 billion expected. This was driven by the continued strong contributions from each of Cigna’s ongoing businesses.

— Health Services adjusted revenues soared to $24.9 billion from $1.11 billion a year ago, driven by the combination with Express Scripts.

— Adjusted revenue from Integrated Medical grew by 12% led by Commercial customer growth and deepening of relationships, as well as premium increases consistent with underlying cost trends.

— The total medical customer base at third-quarter was 17.1 million, an organic increase of 212,000 over last year, driven by growth in the Select and Middle Market segments.

— Looking ahead into the full year 2019, the company now expects an adjusted revenue of about $138 billion and adjusted income from operations of $16.80 to $17 per share. The Street estimates earnings of $16.8 per share on revenue of $136.79 billion.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT